MARKET

ADXN

ADXN

Addex Therapeutics Ltd
NASDAQ
8.21
0.00
0.00%
Opening 09:30 05/22 EDT
OPEN
--
PREV CLOSE
8.21
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
13.27
52 WEEK LOW
6.51
MARKET CAP
8.78M
P/E (TTM)
0.8633
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ADXN last week (0512-0516)?
Weekly Report · 3d ago
Weekly Report: what happened at ADXN last week (0505-0509)?
Weekly Report · 05/12 09:41
Weekly Report: what happened at ADXN last week (0428-0502)?
Weekly Report · 05/05 09:41
Addex Therapeutics enters collaboration with Sinntaxis AB
TipRanks · 04/30 09:40
ADDEX ENTERS OPTION AGREEMENT WITH SINNTAXIS FOR AN EXCLUSIVE LICENSE TO INTELLECTUAL PROPERTY COVERING THE USE OF MGLU5 INHIBITORS IN BRAIN INJURY RECOVERY
Reuters · 04/30 05:00
Addex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges
TipRanks · 04/29 00:01
Weekly Report: what happened at ADXN last week (0421-0425)?
Weekly Report · 04/28 09:44
Addex Therapeutics Reports Strong 2024 Financial Turnaround
TipRanks · 04/26 03:53
More
About ADXN
Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration trials for PD-LID, and ADX71149 (mGlu2 positive allosteric modulator or PAM), which is being developed in collaboration by its partner Janssen Pharmaceuticals, Inc to treat schizophrenia and anxious depression. It also is advancing several preclinical programs, including GABABPAM for pain, overactive bladder and other disorders, mGlu7 NAM for post-traumatic stress disorder, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson’s disease and mGlu3 PAM for neurodegenerative disorders.

Webull offers Addex Therapeutics Ltd - ADR stock information, including NASDAQ: ADXN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADXN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADXN stock methods without spending real money on the virtual paper trading platform.